The 3D-pharmacophore models that retrieved compound 11 and the associated binding sites from the MD trajectory can be used successfully for further virtual screening campaigns and the de novo design of novel Hsp90 CTD inhibitors and compounds with antiproliferative activity in cancer cell lines. Here, HSP90AB1 is linked to cancer.